UBS.NYSEUbs Group AG

4/A: UBS Group AG Corrects Form 4 Filing for ENDRA Life Sciences, Clarifies Ownership Percentage

Sentiment:

SEC Filing (Form 4 Amendment)

📋All filings for Ubs Group AG
🔒Login to Follow

UBS Group AG files an amended Form 4 to correct an initial filing, clarifying that it never beneficially owned more than 10% of ENDRA Life Sciences shares due to warrant exercises affecting the total outstanding share count.

Summary

  • UBS Group AG filed an amended Form 4 on September 5, 2024, to correct a previous filing made on August 29, 2024.
  • The amendment clarifies that UBS Group AG, acting on behalf of UBS Securities LLC and UBS Financial Services Inc., never beneficially owned more than 10% of ENDRA Life Sciences Inc. shares.
  • The correction was prompted by warrant exercises on August 27, 2024, which increased the total outstanding common shares of ENDRA Life Sciences to 16,932,593.
  • The initial Form 4 was deemed erroneous and unnecessary after the revised share count was considered.

Sentiment

Score: 7

Explanation: The document is a routine correction of a regulatory filing. While it indicates a previous error, the prompt correction is a positive sign of compliance.

Negatives

  • The initial Form 4 filing by UBS Group AG was erroneous, requiring an amendment.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership of company stock, ensuring transparency in the market.

Stakeholder Impact

  • The correction ensures accurate information is available to shareholders regarding UBS Group AG's ownership stake in ENDRA Life Sciences.

Key Dates

DateDescription
08/27/2024Date of warrant exercises affecting ENDRA Life Sciences' total outstanding common shares.
08/27/2024Date of transaction (purchase of common stock).
08/29/2024Date of original Form 4 filing.
09/05/2024Date of amended Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.